Drug-Eluting Stent Thrombosis. Increasingly Recognized But Too Frequently Overemphasized* * Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology

Journal of the American College of Cardiology

Volumn 48, Issue 1, 2006, Pages 203-205

  Colombo, Antonio ^a   Corbett, Simon J ^a  

^a EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRIN;

ARTERY INTIMA PROLIFERATION; CORONARY STENT; DRUG ELUTING STENT; DRUG WITHDRAWAL; EDITORIAL; HUMAN; MAINTENANCE THERAPY; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS;

CORONARY THROMBOSIS; CORONARY VESSELS; HUMANS; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; SIROLIMUS; STENTS; WOUND HEALING;

EID: 33745259274     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.04.040     Document Type: Editorial

References (15)

1. Weisz G., Moses J.W., Schofer J., et al. Late stent thrombosis in sirolimus-eluting versus bare metal stents in 4 randomized clinical trials with 3-year follow-up. J Am Coll Cardiol 47 Suppl B:8B (2006)
2. Moreno R., Fernández C., Hernández R., et al. Drug-eluting stent thrombosis results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45 (2005) 954-959
3. McFadden E.P., Stabile E., Regar E., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521
4. Ong A.T., Hoye A., Aoki J., et al. Thirty day incidence and six-month clinical outcome of thrombotic stent occlusion after bare metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 45 (2005) 947-953
5. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
6. Kuchulakanti P.K., Chu W.W., Torguson R., et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113 (2006) 1108-1113
7. Colombo A., Grube E., Koglin J., et al. Early and late stent thrombosis after paclitaxel-eluting stents. analysis from the integrated TAXUS randomized trial program. J Am Coll Cardiol 47 Suppl A (2006) 221A
8. Pfisterer ME, Kaiser CA, Bader F, et al. Late clinical events related to late stent thrombosis after stopping clopidogrel: prospective randomized comparison between drug-eluting versus bare-metal stenting. Available at: http://www.cardiosource.com/pops/trailSum.asp?trialID=1424. Accessed April 27, 2006.
9. Cutlip D.E., Baim D.S., Ho K.K., et al. Stent thrombosis in the modern era. a pooled analysis of multicenter coronary stent clinical trials. Circulation 103 (2001) 1967-1971
10. Urban P., Gershlick A.H., Guagliumi G., et al. Safety of coronary sirolimus-eluting stents in daily clinical practice one-year follow-up of the e-Cypher registry. Circulation 113 (2006) 1434-1441
11. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in man. delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
12. Kotani J., Nanto S., Morozumi T., et al. Angioscopic findings of the neo-intimal coverage over the sirolimus-eluting stent. nine months follow-up study. J Am Coll Cardiol 47 Suppl B (2006) 27B
13. Nebeker J.R., Virmani R., Bennett C.L., et al. Hypersensitivity cases associated with drug-eluting coronary stents. A review of available cases from the research on adverse drug events and reports (RADAR) project. J Am Coll Cardiol 47 (2006) 175-181
14. Mehilli J., Kastrati A., Wessely R., et al. Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss. Circulation 113 (2006) 273-279
15. Serruys P.W., Sianos G., Abizaid A., et al. The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform. The Paclitaxel In-Stent Controlled Elution Study (PISCES). J Am Coll Cardiol 46 (2005) 253-260